Ondansetron: small increased risk of oral clefts following use in the first 12 weeks of pregnancy

In this alert, healthcare professionals are advised that if the clinical decision is made to offer ondansetron in pregnancy, women must be counselled on the potential benefits and risks of use, both to her and to her unborn baby and the final decision should be made jointly.


Medicines and Healthcare products Regulatory Agency